Characterization of HCMV UL84

HCMV UL84 的表征

基本信息

  • 批准号:
    8650248
  • 负责人:
  • 金额:
    $ 31.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-01-15 至 2017-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Since the elucidation of the viral-encoded factors required for lytic DNA replication it is clear that UL84 has emerged as the central factor proposed to be involved in the regulation and coordination of initiation of viral DNA synthesis. Our laboratory and others demonstrated that UL84 is a multifunctional phosphorylated and ubiquinated protein that displays nucleocytoplasmic shuttling, interacts with viral proteins IE2, UL44, UL83 and binds to RNA and DNA. Recent proteomics data from our laboratory revealed the cellular and viral binding partners for UL84 in infected cells. These discoveries have now illuminated new areas of research with respect to understanding the precise role of UL84 in HCMV growth. We have now demonstrated that UL84 interacts with the cellular kinase Casein Kinase II (CK2) and two amino acid residues within the UL84 mediated this interaction. Mutation of these two amino acid residues (aa 148 and 157) results in the inability of CK2 to interact with UL84. Mutation of these residues renders UL84 incapable of complementing oriLyt-depended DNA replication, suggesting that phosphorylation is an essential modification for the replication function of UL84. Additionally, we also show that UL84 interacts with UL44, the pol accessory protein. The binding of UL84 with UL44 suggests that the pol accessory protein may act as a cofactor for the interaction of UL84 with oriLyt and possibly recruits UL44 to oriLyt as part of the replication complex. Additionally, we now show that UL84 interacts with CCAAT/enhancer binding (C/EBP) transcription factor-binding sites within oriLyt in the absence of C/EBP, and these sites are essential for oriLyt-dependent DNA replication. This is the first reporting of a defined binding site for UL84 in oriLyt. We also demonstrate that the nuclear export activity of UL84 is essential for oriLyt-dependent DNA replication and in the context of the virus genome. This suggests that UL84 interacts with viral and/or cellular mRNA and this interaction plays an essential role in virus replication. Using an UL84-RNA pull down assay we have identified the viral mRNA encoding IRS1 as one transcript associated with UL84. This proposal will seek to determine a role for the posttranslational modifications of ubiquitination and CK2-mediated phosphorylation and elucidate the complete set of cellular/viral factors interacting with specific elements within oriLyt. Lastly, we will determine specific RNA species interacting with UL84 and how nucleocytoplasmic shuttling contributes to the regulation of DNA synthesis.
描述(由申请人提供):自从阐明了裂解DNA复制所需的病毒编码因子后,很明显UL84已成为参与调节和协调病毒DNA合成启动的中心因子。我们的实验室和其他人证明了UL84是一种多功能的磷酸化和泛化的蛋白质,它显示出核质穿梭,与病毒蛋白IE2,UL44,UL83相互作用,并与RNA和DNA结合。我们实验室最近的蛋白质组学数据揭示了感染细胞中UL84的细胞和病毒结合伙伴。这些发现现在为了解UL84在巨细胞病毒生长中的确切作用提供了新的研究领域。我们现在已经证明了UL84与细胞酪蛋白激酶II(CK2)相互作用,并且UL84中的两个氨基酸残基介导了这种相互作用。这两个氨基酸残基(aa148和157)的突变导致CK2不能与UL84相互作用。这些残基的突变使UL84不能补充oriLyt依赖的DNA复制,表明磷酸化是UL84复制功能的重要修饰。此外,我们还发现UL84与POL辅助蛋白UL44相互作用。UL84与UL44的结合表明POL辅助蛋白可能是UL84与oriLyt相互作用的辅助因子,并可能招募UL44作为复制复合体的一部分。此外,我们现在发现UL84在没有C/EBP的情况下与oriLyt内的CCAAT/增强子结合(C/EBP)转录因子结合位点相互作用,这些位点对于oriLyt依赖的DNA复制是必不可少的。这是在oriLyt中首次报道UL84的已定义结合位点。我们还证明了UL84的核输出活性对于oriLyt依赖的DNA复制和在病毒基因组中是必不可少的。这表明UL84与病毒和/或细胞内的mRNA相互作用,这种相互作用在病毒复制中起着至关重要的作用。使用UL84-RNA下拉试验,我们已经鉴定了编码IRS1的病毒mRNA是与UL84相关的一个转录本。这项建议将寻求确定泛素化和CK2介导的磷酸化的翻译后修饰的作用,并阐明与oriLyt中特定元件相互作用的一整套细胞/病毒因子。最后,我们将确定特定的RNA物种与UL84相互作用,以及核质穿梭如何有助于DNA合成的调节。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Analysis of the interactions of viral and cellular factors with human cytomegalovirus lytic origin of replication, oriLyt.
  • DOI:
    10.1016/j.virol.2011.12.010
  • 发表时间:
    2012-03-15
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Kagele D;Rossetto CC;Tarrant MT;Pari GS
  • 通讯作者:
    Pari GS
Interaction of HCMV UL84 with C/EBPalpha transcription factor binding sites within oriLyt is essential for lytic DNA replication.
  • DOI:
    10.1016/j.virol.2009.06.035
  • 发表时间:
    2009-09-15
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Kagele, Dominique;Gao, Yang;Smallenburg, Kate;Pari, Gregory S.
  • 通讯作者:
    Pari, Gregory S.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Cyprian Constance Rossetto其他文献

Cyprian Constance Rossetto的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Cyprian Constance Rossetto', 18)}}的其他基金

Changes in viral and cellular gene expression mediated by KSHV PAN lncRNA
KSHV PAN lncRNA 介导的病毒和细胞基因表达的变化
  • 批准号:
    9203912
  • 财政年份:
    2016
  • 资助金额:
    $ 31.27万
  • 项目类别:
Changes in viral and cellular gene expression mediated by KSHV PAN lncRNA
KSHV PAN lncRNA 介导的病毒和细胞基因表达的变化
  • 批准号:
    9915852
  • 财政年份:
    2016
  • 资助金额:
    $ 31.27万
  • 项目类别:
Elucidation of HCMV latent viral genome maintenance/replication factors
阐明 HCMV 潜伏病毒基因组维持/复制因子
  • 批准号:
    8905152
  • 财政年份:
    2014
  • 资助金额:
    $ 31.27万
  • 项目类别:

相似海外基金

Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
  • 批准号:
    BB/Y006380/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.27万
  • 项目类别:
    Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
  • 批准号:
    24K17112
  • 财政年份:
    2024
  • 资助金额:
    $ 31.27万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
  • 批准号:
    23K04668
  • 财政年份:
    2023
  • 资助金额:
    $ 31.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
  • 批准号:
    23K06918
  • 财政年份:
    2023
  • 资助金额:
    $ 31.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
  • 批准号:
    23K05758
  • 财政年份:
    2023
  • 资助金额:
    $ 31.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
  • 批准号:
    2888395
  • 财政年份:
    2023
  • 资助金额:
    $ 31.27万
  • 项目类别:
    Studentship
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
  • 批准号:
    2300890
  • 财政年份:
    2023
  • 资助金额:
    $ 31.27万
  • 项目类别:
    Continuing Grant
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 31.27万
  • 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
  • 批准号:
    10728925
  • 财政年份:
    2023
  • 资助金额:
    $ 31.27万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 31.27万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了